About Hanh

This author has not yet filled in any details.
So far Hanh has created 135 blog entries.

PRESS RELEASE: IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment

IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment at Xtelligent Media’s Value Based Summit 2018 Boston, MA –- October 18, 2018 -- Value Assessment 2.0 requires building assessment models that account for all of the factors that determine value instead of focusing only on cost and clinical benefits, said the executive director [...]

2018-10-18T18:49:30+00:00October 18th, 2018|Events, IVI News, Press|

PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies

Priorities Emerged Which Will Shape Version 2.0 of IVI’s RA Model Los Angeles, CA – September 20, 2018 -- The Innovation and Value Initiative (IVI) today released public feedback and recommendations from its Technical Expert Panel (TEP), an objective third party comprised of five leaders in health economics, epidemiology, rheumatology, and patient communities, which the [...]

2018-09-20T09:03:25+00:00September 20th, 2018|IVI News, Press, Research|

Precision Benefit Design: How should the arrival of precision medicine affect health plan benefit design?

Advances in precision medicine offer the promise of tre­mendous gains in patient health over the coming de­cades. Headlines in the popular press as well as discussions at academic conferences tout the potential benefits of precision medicine, while at the same time critiquing the nascent but growing evidence base and the high cost of treatment. One [...]

2018-10-22T08:02:04+00:00September 13th, 2018|IVI News, Viewpoints|

Is One Answer Good Enough for All? Defining Value in Healthcare

While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI's Jennifer Bright and Mark Linthicum address this concern in a recent article for the American Journal of Managed Care (AJMC). Read the [...]

2018-09-11T16:59:01+00:00August 22nd, 2018|IVI News, Viewpoints|

Why Quality Measures Must Reflect Patient Values, Care Experience

There isn't an easy answer to assessing value in healthcare, but IVI is working to tackle the problems through considerable research and experimentation by developing an open-source value platform that considers no only clinical factors, but patient perspectives as well. In a recent interview with PatientEngagementHIT.com, IVI's Jennifer Bright (Executive Director) and Mark Linthicum (Director [...]

2018-08-24T13:13:25+00:00August 20th, 2018|IVI News, Viewpoints|

Is Using Centralized Value Assessment to Make Centralized Pricing Decisions the Most Effective Path Forward?

The Pink Sheet article described comment letters to HHS’ drug pricing blueprint recommending that cost-effectiveness analyses by ICER could help promote value-based pricing in government-sponsored insurance. While IVI concurs value assessment is noble, worthwhile and needed, IVI cautions about making centralized pricing decisions based on centralized value assessments within the U.S.’s current decentralized health care [...]

2018-08-20T12:05:07+00:00August 20th, 2018|IVI News|

IVI Provides Insight into CVS Health’s Decision to Include Cost-per-QALY Analyses from ICER into Formulary Decision-Making

CVS Health's pharmacy benefit management (PBM) division, CVS Caremark, recently announced their decision to rely exclusively on the analyses of the Institute for Clinical and Economic (ICER) in a new drug management program. IVI's Director of Scientific Communications, Mark Linthicum, responds to this story in MedCity stating, "The neat 'answer' regarding the value of treatment [...]

2018-08-24T13:20:36+00:00August 17th, 2018|IVI News, Viewpoints|

How to Improve Value Assessment

In an op-ed published in Healthcare Business News, IVI's Executive Director, Jennifer Bright, describes four essential steps necessary to better measure value in healthcare: Better value measurement must incorporate the patient perspective into all assessment tools. Real world data must be considered when determining a treatment's worth beyond direct clinical benefit. Value assessments must be [...]

2018-07-27T12:03:59+00:00July 27th, 2018|Viewpoints|

PRESS RELEASE: IVI Responds to HHS’ Blueprint Saying Lowering Healthcare Costs Requires Improving Value Assessment

IVI Says Moving Beyond Cost Effectiveness by Evaluating Treatments Based on Unique Patient Characteristics and Preferences is Imperative Los Angeles, CA – July 16, 2018 -- If we are going to truly harness data to lower healthcare costs while accelerating and rewarding innovation that benefits patients, then defining and assessing value in healthcare must [...]

2018-07-17T09:48:32+00:00July 16th, 2018|IVI News, Press|

Current Problems with Value Assessments and Ideas for Improvement

In an op-ed published by Fierce Healthcare, Director of Scientific Communications, Mark Linthicum discusses current shortfalls of value assessment and what is needed to move to value assessment 2.0. Read the full article here.

2018-07-11T14:10:32+00:00July 11th, 2018|Viewpoints|